Alexpandi, R., De Mesquita, J. F., Pandian, S. K., & Ravi, A. V. (2020). Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis. Front Microbiol.
Chicago Style CitationAlexpandi, Rajaiah, Joelma Freire De Mesquita, Shunmugiah Karutha Pandian, and Arumugam Veera Ravi. "Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in Silico Analysis." Front Microbiol 2020.
MLA CitationAlexpandi, Rajaiah, Joelma Freire De Mesquita, Shunmugiah Karutha Pandian, and Arumugam Veera Ravi. "Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in Silico Analysis." Front Microbiol 2020.